, of dimer formation and intracellular localization, Cell, vol.103, pp.645-654

K. Wang, X. M. Yin, D. T. Chao, C. L. Milliman, and S. J. Korsmeyer, Bid: a novel bh3 domain-only death agonist, Genes Dev, vol.10, pp.2859-2869, 1996.

M. C. Wei, T. Lindsten, V. K. Mootha, S. Weiler, A. Gross et al., tBID, a membranetargeted death ligand, oligomerizes BAK to release cytochrome c, Genes Dev, vol.14, pp.2060-2071, 2000.

M. C. Wei, W. X. Zong, E. H. Cheng, T. Lindsten, V. Panoutsakopoulou et al., Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death, Science, vol.292, pp.727-730, 2001.

J. Yu and L. Zhang, No PUMA, no death: implications for p53-dependent apoptosis, Cancer Cell, vol.4, pp.248-249, 2003.

W. X. Zong, T. Lindsten, A. J. Ross, G. R. Macgregor, and C. B. Thompson, BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak, Genes Dev, vol.15, pp.1481-1486, 2001.